Decent Value Stocks. Analyze the stocks with a good fundamental valuation, while still showing decent profitability, health and growth.
We assign a fundamental rating of 7 out of 10 to MRK. MRK was compared to 198 industry peers in the Pharmaceuticals industry. MRK gets an excellent profitability rating and is at the same time showing great financial health properties. MRK is valued quite cheap, while showing a decent growth score. This is a good combination! Finally MRK also has an excellent dividend rating. With these ratings, MRK could be worth investigating further for value and dividend and quality investing!.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 14.62% | ||
ROE | 36.96% | ||
ROIC | 19.77% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 34.59% | ||
PM (TTM) | 26.68% | ||
GM | 78.19% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.74 | ||
Debt/FCF | 2.05 | ||
Altman-Z | 3.69 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.36 | ||
Quick Ratio | 1.15 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 10.25 | ||
Fwd PE | 8.64 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 10.89 | ||
EV/EBITDA | 8.2 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 4.15% |